Arrowhead Pharmaceuticals (ARWR) stock jumps as the company posts a late-stage trial win for lipid drug plozasiran, hurting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results